Malaria and onchocerciasis: On HLA and related matters

Weidanz, 1988, The role of T cells in immunity to malaria, Prog. Allery, 41, 215 Troye-Blomberg, 1994, Human T-cell responses to blood stage antigens in Plasmodium falciparum malaria, Immunol. Lett., 41, 103, 10.1016/0165-2478(94)90116-3 Gallin, 1988, Cell-mediated immune response in human infection with Onchocerca volvulus, J. Immunol., 140, 1999, 10.4049/jimmunol.140.6.1999 Ward, 1988, Onchocerciasis and immunity in humans: enhanced T cell responsiveness to parasite antigen in putatively immune individuals, J. Infect. Dis., 157, 536, 10.1093/infdis/157.3.536 King, 1991, A54 Bjorkmann, 1987, The foreign antigen binding site and T cell recognition of class I histocompatibility antigens, Nature, 329, 512, 10.1038/329512a0 Brown, 1993, Three dimensional structure of the human class II histocompatibility antigen HLA-DR1, Nature, 364, 33, 10.1038/364033a0 Amiel, 1967, 79 Brewerton, 1973, Ankylosing spondylitis and HLA-A27, Lancet, i, 904, 10.1016/S0140-6736(73)91360-3 Schlosstein, 1973, High association of a HLA antigen, w27, with ankylosing spondylitis, N. Engl. J. Med., 288, 704, 10.1056/NEJM197304052881403 Tiwari, 1985 Hill, 1991, Common West African HLA antigens are associated with protection from severe malaria, Nature, 352, 595, 10.1038/352595a0 Meyer, 1994, HLA-D alleles associated with generalized disease, localized disease, and putative immunity in Onchocerca volvulus infection, 91, 7515 Wassom, 1984, H-2 controlled, dose-dependent suppression of the response that expels adult Trichinella spiralis from the small intestine of mice, Immunology, 53, 811 WHO, 1994, World malaria situation in 1992, Weekly Epidemiol. Rec., 69, 309 Eling, 1994, Cytokines in malaria, pathology and protection, Biotherapy, 7, 211, 10.1007/BF01878487 Grau, 1989, Tumor necrosis factor and disease severity in children with Plasmodium falciparum malaria, N. Engl. J. Med., 320, 1586, 10.1056/NEJM198906153202404 McGuire, 1994, Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria, Nature, 371, 508, 10.1038/371508a0 Grau, 1987, Tumor necrosis factor/cachectin as an essential mediator in murine cerebral malaria, Science, 237, 1210, 10.1126/science.3306918 Kremsner, 1991, Pentoxifylline prevents murine cerebral malaria, J. Infect. Dis., 164, 605, 10.1093/infdis/164.3.605 Kremsner, 1995, Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor production, Am. J. Trop. Med. Hyg., 53, 532, 10.4269/ajtmh.1995.53.532 Clark, 1983, Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria, Infect. Immun., 39, 1, 10.1128/IAI.39.1.1-6.1983 Senaldi, 1992, Nitric oxide and cerebral malaria, Lancet, 340, 1554, 10.1016/0140-6736(92)92812-T Rockett, 1991, Killing of Plasmodium falciparum in vitro by nitric oxide derivatives, Infect. Immun., 59, 3280, 10.1128/IAI.59.9.3280-3283.1991 Kremsner, 1992, Interferon-γ induced lethality in the late phase of Plasmodium vinckei malaria despite effective parasite clearance by chloroquine, Eur. J. Immunol., 22, 2873, 10.1002/eji.1830221118 Cui, 1994, Nitric oxide in cerebral malaria, J. Infect. Dis., 169, 1417, 10.1093/infdis/169.6.1417 Thumwood, 1989, Antioxidants can prevent cerebral malaria in Plasmodium bergtei-infected mice, Br. J. Exp. Pathol., 70, 293 Kremsner, 1990, Immune response during and after Plasmodium falciparum infection, J. Infect. Dis., 161, 1025, 10.1093/infdis/161.5.1025 Kremsner, 1989, Soluble CD8 antigen in Plasmodium falciparum malaria, J. Infect. Dis., 160, 357, 10.1093/infdis/160.2.357 Hoffmann, 1989, Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes, Science, 244, 1078, 10.1126/science.2524877 Gupta, 1994, Parasite virulence and disease patterns in Plasmodium falciparum malaria, 91, 3715 Quakyi, 1994, Analysis of human T cell clones specific for conserved peptide sequences within malaria proteins, J. Immunol., 153, 2082, 10.4049/jimmunol.153.5.2082 Wirtz, 1987, Plamodium berghei: cloning of the circumsporozoite protein gene, Exp. Parasitol., 63, 166, 10.1016/0014-4894(87)90158-5 Hoffman, 1989, Immune response gene regulation of immunity to Plasmodium berghei sporozoites and circumsporozoite vaccines, J. Immunol., 142, 3581, 10.4049/jimmunol.142.10.3581 Miller, 1994, Impact of malaria on genetic polymorphism and genetic diseases in Africans and African Americans, 91, 2415 Hill, 1992, Molecular analysis of the association of HLA-B53 and resistance to severe malaria, Nature, 360, 434, 10.1038/360434a0 Zhu, 1991, Structure of Plasmodium falciparum liver stage antigen 1, Mol. Biochem. Parasitol., 48, 223, 10.1016/0166-6851(91)90117-O Malik, 1991, Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein, 88, 3300 Alonso, 1994, Randomized trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania, Lancet, 344, 1175, 10.1016/S0140-6736(94)90505-3 D'Allesandro, 1995, Efficacy trial of malaria vaccine Spf66 in Gambian infants, Lancet, 346, 462, 10.1016/S0140-6736(95)91321-1 Riley, 1992, MHC and malaria: the relationship between HLA class II alleles and immune responses to Plasmodium falciparum, Intern. Immunol., 4, 1055, 10.1093/intimm/4.9.1055 Bennet, 1993, Human leucocyte antigen (HLA) and malaria morbidity in a Gambian community, Trans. R. Soc. Trap. Med. Hyg., 87, 286, 10.1016/0035-9203(93)90130-I Riley, 1990, Cellular and humoral responses to Plasmodium falciparum gametocyte antigens in malaria-immune individuals: limited respopnse to the 48/45 kD surface antigen does not appear to be due to MHC restriction, J. Immunol., 144, 4810, 10.4049/jimmunol.144.12.4810 Riley, 1994, Human antibody responses to Pfs 230, a sexual stage-specific surface antigen of Plasmodium falciparum: non-responsiveness is a stable phenotype but does not appear to be genetically regulated, Parasite Immunol., 16, 55, 10.1111/j.1365-3024.1994.tb00323.x WHO, 1987, Expert Committee on onchocerciasis, 752 Tsang, 1991, Guatemalan human onchocerciasis. I. Systematic analysis of patient populations, nodular antigens, and specific isotypic reactions, J. Immunol., 146, 3993, 10.4049/jimmunol.146.11.3993 Boyer, 1991, Guatemalan human onchocerciasis. II. Evidence for IgG3 involvement in acquired immunity to Onchocerca volvulus and identification of possible immune-associated antigens, J. Immunol., 146, 4001, 10.4049/jimmunol.146.11.4001 Elson, 1994, Immunity to onchocerciasis: identification of a putative immune population in a hyperendemic area of Ecuador, J. Infect. Dis., 169, 588, 10.1093/infdis/169.3.588 Elson, 1995, Immunity to onchocerciasis: Putative immune persons produce a Th1-like response to Onchocerca volvulus, J. Infect. Dis., 171, 652, 10.1093/infdis/171.3.652 Greene, 1985, Humoral and cellular immune responses to Onchocerca volvulus infection in humans, Rev. Infect. Dis., 7, 789, 10.1093/clinids/7.6.789 Ottesen, 1985, Immediate hypersensitivity responses in the immunopathogenesis of human onchocerciasis, Rev. Infect. Dis., 7, 796, 10.1093/clinids/7.6.796 Ottesen, 1992, Infection and disease in lymphatic filariasis: an immunological perspective, Parasitology, 104, S71, 10.1017/S0031182000075259 Murdoch, 1992, The skin and the immune response in onchocerciasis, Trop. Doc., 22, 44, 10.1177/00494755920220S109 Kazura, 1993, 473 Ottesen, 1995, Immune responsiveness and the pathogenesis of human onchocerciasis, J. Infect. Dis., 171, 659, 10.1093/infdis/171.3.659 Greene, 1983, Non-specific suppression of antigen-induced lymphocyte blastogenesis in Onchocerca volvulus infection in man, Clin. Exp. Immunol., 52, 259 Elkhalifa, 1991, Suppression of human lymphocyte responses to specific and non-specific stimuli in human onchocerciasis, Clin. Exp. Immunol., 86, 433, 10.1111/j.1365-2249.1991.tb02949.x Soboslay, 1992, Ivermectin-facilitated immunity in onchocerciasis, 89, 407 Merino, 1977, Immunological studies in onchocerciasis patients, Trop. Med. Parasitol., 28, 229 Ndiaye, 1987, Les facteurs humoraux et cellulaires de l'immunité au cours de l'onchocercose (résultats d'études effectuées aus Senegal), Bull. Soc. Pathol. Exot., 80, 230 Brattig, 1994, Strong immunoglobulin G isotypic antibody response in Sowdah type onchocerciasis, J. Infect. Dis., 170, 955, 10.1093/infdis/170.4.955 Dafa'Alla, 1992, The profile of IgG and IgG subclasses of onchocerciasis patients, Clin. Exp. Immunol., 88, 258, 10.1111/j.1365-2249.1992.tb03070.x Ottesen, 1987, Description, mechanisms and control of reactions to treatment in the human filariases, 127, 265 Soboslay, 1994, Ivermectin-facilitated immunity in onchocerciasis: activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection, Clin. Exp. Immunol., 96, 238, 10.1111/j.1365-2249.1994.tb06548.x Thambiah, 1992, Identification and characterization of a parasite antigen in the circulating immune complexes of Onchocerca volvulus-infected patients, Trop. Med. Parasitol., 48, 271 Nutman, 1987, Parasite specific anergy in human filariasis: insights after analysis of parasite antigen-driven lymphokine production, J. Clin. Invest., 79, 1516, 10.1172/JCI112982 Kilian, 1989, Cell-mediated and humoral immune response to tetanus vaccinations in onchocerciasis patients, Trop. Med. Parasitol., 40, 445 Wassom, 1987, I-E expression and susceptibility to parasite infection, Immunol. Today, 8, 39, 10.1016/0167-5699(87)90236-2 Kennedy, 1991, MHC class II (I-A) region control of the IgE antibody repertoire to the ABA-1 allergen of the nematode Ascaris, Immunology, 71, 577 Behnke, 1991, Immunological relationships during primary infection with Heligmosomoides polygyrus (Nematospiroides dubius): H-2 linked genes determine worm survival, Parasitology, 103, 157, 10.1017/S0031182000059400 Brattig, 1986, Differences in the distribution of HLA antigens in localized and generalized form of onchocerciasis, Trop. Med. Parasitol., 37, 271 Meyer, C.G., Schnittger, L. and May, J. Met-11 of HLA class II DPα1 first domain associated with onchocerciasis. Exp. Clin. Immunogenet. (in press) Benacerraf, 1991, Role of MHC gene products in immune regulation, Science, 212, 1229, 10.1126/science.6165083 Murray, 1992, Major histocompatibility complex (MHC) control of CD4 T cell subset activation, II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype, Eur. J. Immunol., 22, 559, 10.1002/eji.1830220239 Hirayama, 1987, HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans, Nature, 327, 426, 10.1038/327426a0 Sasazuki, 1989, HLA-linked immune suppression in humans, Immunology Suppl., 2, 21 Salgame, 1991, Immunological suppression by human CD8+ T cells is receptor dependent and HLA-DQ restricted, 88, 2598 Bloom, 1992, Revisiting and revising suppressor T cells, Immunol. Today, 13, 131, 10.1016/0167-5699(92)90110-S Ottenhoff, 1986, Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells, Nature, 322, 462, 10.1038/322462a0 Nutman, 1984, Parasite antigen-specific human T cell lines and clones, 73, 1754 Alemann, 1991, What is the basis for HLA-DQ association with autoimmune disease?, Immunol. Today, 12, 267, 10.1016/0167-5699(91)90124-C Ishikura, 1987, Differential expression of HLA class II antigens in the human thymus, 44, 314 Gallin, 1995, Human autoantibody to defensin: disease association with hyperreactive onchocerciasis (Sowda), J. Exp. Med., 182, 41, 10.1084/jem.182.1.41